Your browser doesn't support javascript.
loading
Outcome of chimeric antigen receptor T-cell therapy following treatment with inotuzumab ozogamicin in children with relapsed or refractory acute lymphoblastic leukemia.
Ceolin, Valeria; Brivio, Erica; van Tinteren, Harm; Rheingold, Susan R; Leahy, Allison; Vormoor, Britta; O'Brien, Maureen M; Rubinstein, Jeremy D; Kalwak, Krzysztof; De Moerloose, Barbara; Jacoby, Elad; Bader, Peter; López-Duarte, Mónica; Goemans, Bianca F; Locatelli, Franco; Hoogerbrugge, Peter; Calkoen, Friso G; Zwaan, Christian Michel.
Afiliação
  • Ceolin V; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • Brivio E; Department of Pediatric Oncology/Hematology, Regina Margherita Children's Hospital, University of Turin, Turin, Italy.
  • van Tinteren H; Department of Pediatric Oncology/Hematology, Erasmus University MC-Sophia Children's Hospital, Rotterdam, The Netherlands.
  • Rheingold SR; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • Leahy A; Department of Pediatric Oncology/Hematology, Erasmus University MC-Sophia Children's Hospital, Rotterdam, The Netherlands.
  • Vormoor B; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • O'Brien MM; Division of Pediatric Oncology, Children's Hospital of Philadelphia, Perelman School of Medicine, Philadelphia, PA, USA.
  • Rubinstein JD; Division of Pediatric Oncology, Children's Hospital of Philadelphia, Perelman School of Medicine, Philadelphia, PA, USA.
  • Kalwak K; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • De Moerloose B; Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
  • Jacoby E; Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
  • Bader P; Department of Pediatric Hematology, Oncology and Bone Marrow Transplantation, Wroclaw Medical University, Wroclaw, Poland.
  • López-Duarte M; Department of Pediatric Oncology/Hematology and Stem Cell Transplantation, Ghent University Hospital, Ghent, Belgium.
  • Goemans BF; Division of Pediatric Hematology, Oncology and BMT, The Edmond and Lily Safra Children's Hospital, Sheba Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Locatelli F; Department of Pediatric Oncology/Hematology, Clinic for Children and Youth Medicine, University Hospital Frankfurt, Goethe University, Frankfurt, Germany.
  • Hoogerbrugge P; Pediatric Hematology Unit, Hematology Department, Hospital de Valdecilla, Santander, Spain.
  • Calkoen FG; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • Zwaan CM; Department of Hematology/Oncology and Cell and Gene Therapy, IRCCS Bambino Gesù Children's Hospital, Catholic University of the Sacred Heart, Rome, Italy.
Leukemia ; 37(1): 53-60, 2023 01.
Article em En | MEDLINE | ID: mdl-36310183
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras / Receptores de Antígenos Quiméricos Limite: Adolescent / Adult / Child / Child, preschool / Humans / Infant Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Holanda
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras / Receptores de Antígenos Quiméricos Limite: Adolescent / Adult / Child / Child, preschool / Humans / Infant Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Holanda